AVE 33.3% 0.2¢ avecho biotechnology limited

oxymorphone patch m eets phase 1 end points, page-31

  1. 5,322 Posts.
    I believe we have too many holders on the registry who are clearly bored and impatient with the commercial rollout. POH mgmt need to put some sizzle into the story . Re-engage holders and get them excited about what is coming . A deal will blow the sp skyward. We all know this. So chill and be patient . And from that first deal forward POH will get plenty of market attention which will see the sp chased higher and higher with each successive milestone. It's not far away and I'm going the distance .
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.2¢ 0.3¢ 0.2¢ $16.54K 5.758M

Buyers (Bids)

No. Vol. Price($)
59 96791453 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 58594028 16
View Market Depth
Last trade - 16.10pm 02/08/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.